Literature DB >> 12472618

Optimum usage of prilocaine-lidocaine cream in premature ejaculation.

M K Atikeler1, I Gecit, F A Senol.   

Abstract

Premature ejaculation is a common male sexual disorder in which orgasm and ejaculation occur before the desired moment. The primary therapeutic approach to premature ejaculation has been behavioural and pharmacotherapy. In this study, we evaluated the efficacy and optimum usage of lidocaine-prilocaine cream 5% in preventing premature ejaculation. Forty patients were examined in the study group and randomized into four groups, each comprising 10 patients. Patients in group 1 applied lidocaine-prilocaine cream 5% for 20 min, the patients in group 2 applied it for 30 min, and the patients in group 3 applied the cream for 45 min before sexual contact, with all patients covering the penis with a condom. Patients in the fourth group applied a base cream as placebo. In group 1, the pre-ejaculation period increased to 6.71 +/- 2.54 min without any adverse effects. In group 2, although the pre-ejaculation period increased in four patients up to 8.70 +/- 1.70 min, six patients in this group and all patients in group 3 had erection loss because of numbness. In the placebo group, there was no change in their pre-ejaculation period. Therefore, lidocaine-prilocaine cream 5% is effective in premature ejaculation and 20 min of application time before sexual contact is the optimum period.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472618     DOI: 10.1046/j.1439-0272.2002.00511.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  19 in total

1.  Medical therapy for premature ejaculation.

Authors:  Amar Mohee; Ian Eardley
Journal:  Ther Adv Urol       Date:  2011-10

Review 2.  Advances in understanding and treating premature ejaculation.

Authors:  Theodore R Saitz; Ege Can Serefoglu
Journal:  Nat Rev Urol       Date:  2015-10-27       Impact factor: 14.432

3.  In vitro measurement of ejaculation latency time (ELT) and the effects of vardenafil on ELT on lifelong premature ejaculators: placebo-controlled, double-blind, cross-over laboratory setting.

Authors:  Ahmet Gökçe; Abdullah Demirtas; Fikret Halis; Oguz Ekmekcioglu
Journal:  Int Urol Nephrol       Date:  2010-02-20       Impact factor: 2.370

Review 4.  Current therapeutic strategies for premature ejaculation and future perspectives.

Authors:  Zhong-Cheng Xin; Yi-Chen Zhu; Yi-Ming Yuan; Wan-Shou Cui; Zhe Jin; Wei-Ren Li; Tao Liu
Journal:  Asian J Androl       Date:  2011-05-02       Impact factor: 3.285

5.  Evolving therapeutic strategies for premature ejaculation: The search for on-demand treatment - topical versus systemic.

Authors:  Alvaro Morales
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

Review 6.  New insights on premature ejaculation: a review of definition, classification, prevalence and treatment.

Authors:  Ege C Serefoglu; Theodore R Saitz
Journal:  Asian J Androl       Date:  2012-10-15       Impact factor: 3.285

Review 7.  Efficacy and safety of local anaesthetics for premature ejaculation: a systematic review and meta-analysis.

Authors:  Jia-Dong Xia; You-Feng Han; Liu-Hua Zhou; Yun Chen; Yu-Tian Dai
Journal:  Asian J Androl       Date:  2013-05-27       Impact factor: 3.285

Review 8.  Treatment of premature ejaculation: new drugs and treatment strategies.

Authors:  Wayne J G Hellstrom; Jay W Heintz
Journal:  Curr Urol Rep       Date:  2006-11       Impact factor: 2.862

9.  Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation.

Authors:  Ej McCarty; Ww Dinsmore
Journal:  Core Evid       Date:  2012-01-19

10.  Emerging treatments for premature ejaculation: focus on dapoxetine.

Authors:  Wayne J G Hellstrom
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.